PhD MISSION

The PhD program in Oncology, Hematology and Pathology brings together translational and clinical research. The activities include laboratory research, field research, clinical research, and the use of advanced technologies in the field of molecular biology and genetics.

The PhD program therefore directs towards preclinical and clinical research applications and offers wide opportunities to trainees to develop their activities in centers of scientific and clinical excellence.

Current research topics include:

- Clinical and preclinical research on solid tumors (lung, GIST, breast, biliary tract, mesothelioma, colorectal, melanoma, bone sarcoma)
- Clinical and preclinical research on hematologic neoplasms (AML, ALL, MM, CML, CLL, lymphoma)
- Clinical and preclinical research on pediatric onco-hematology
- Preclinical research on aging, longevity and age-associated diseases
- Molecular pathology of infections associated with implants
- Preclinical research on ribosomopathies
- Preclinical research on non-coding RNAs
- Radiotherapy, oncological radiodiagnostics, radiomics and radiobiology
- Shiga toxin and hemolytic uremic syndrome
- Nutrition, microbiota and cancer
- Plant toxins and immunotoxins
- Alterations of protein glycosylation